Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
EDAP TMS SA
Orin Hirschman has filed a Schedule 13G, reporting a beneficial ownership stake of more than 5% in EDAP TMS SA. This filing serves as an official disclosure of the investor's equity position in the company.…more
EDAP TMS SA
EDAP TMS S.A. has adopted the '2026 Restricted Stock Unit (Free Share) Plan' for employees and officers, registering 2,200,000 ordinary shares for this purpose. This initiative aims to attract and retain talent, with the registered shares to be issued upon the vesting of the RSUs.…more
EDAP TMS SA
Investment entities associated with Soleus Capital have filed Form 3 to report their initial beneficial ownership of EDAP TMS SA securities. This filing confirms their status as major shareholders and fulfills their regulatory reporting obligations.…more
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
FocalTherics to Announce Third Quarter 2026 Financial Results on November 5…more
FocalTherics will release its financial results for the third quarter of 2026 after the market closes on November 5. The company will host a conference call and webcast to discuss the results with management.…more
●●●●●●●● ●●●●● ●●●●●●
FocalTherics announced that its management will present and host investor meetings at the upcoming H.C. Wainwright Global Investment Conference in mid-September. This event serves as a standard investor relations activity and does not provide immediate material impact on the stock price.…more
●●●●●●●● ●●●●● ●●●●●●
FocalTherics reported a 39% year-over-year revenue increase in Q2 2026, driven by strong growth in its robotic focal therapy business. The company also announced a $40 million public offering to accelerate global market adoption and product development.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.